Case Report

Trans-Aortic Counterpulsation: A Viable Alternative?

^* Department of Perfusion Services, Southlake Regional Health Centre, Newmarket, Ontario, Canada
^† Department of Anaesthesiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada
^‡ Cardiac Surgery Associates, Newmarket, Ontario, Canada

Address correspondence to: Bharat Datt, MSc, CCP, CPC, Clinical Perfusionist, Department of Perfusion Services, Southlake Regional Health Centre, 596 Davis Drive, Newmarket, Ontario L3Y2P9, Canada. E-mail: bdatt@southlakeregional.org

Abstract

Transthoracic intra-aortic balloon pump (IABP) insertion has been a relatively rare and uncommon procedure. However, it is an established beneficial option in patients with severe peripheral vascular disease (PVD) accompanied with bi-lateral femoral arterial occlusion. There are several viable alternatives to trans-aortic IABP insertion, including trans-axillary or in abdominal aorta (requiring a laparotomy). Cardiac surgery has the advantage of an open sternum, facilitating effortless direct intraaortic balloon (IAB) insertion into the aorta. The IAB can be inserted either through a 9-mm graft or directly into the ascending aorta. During cardiac surgery, direct insertion into the ascending aorta with the balloon tip lying distally in the abdominal aorta is facilitated with an open sternum. The base of the balloon lies ∼2 cm below the left subclavian and can be confirmed through a trans-esophageal echocardiogram (TEE). Elimination of a graft insertion saves the team from time-consuming maneuvers and additional hemorrhagic complications. In our experience, postoperative vasoplegic syndrome coupled with myocardial edema contributed to patent instability and was treated with vasopressin and transthoracic IAB insertion. The CS 100 (Datascope Corp., Mahwah, NJ) console allowed the ability to time the balloon accurately. This case report details our experience with one such patient and establishes trans-aortic counter-pulsation as a safe and viable option in patients with severe PVD, where percutaneous insertion is precluded or has failed.